文献速递胃肠外科肝胆胰外科围术期管理与 ERAS

衰弱风险分析指数能否预测高风险手术患者的并发症与死亡?

Can the Risk Analysis Index for Frailty Predict Morbidity and Mortality in Patients Undergoing High-risk Surgery?
PubMed 文献 · Ann Surg · 2020-11-17

本研究基于美国外科质量改进计划数据库2006至2017年数据,回顾性分析283545例接受结肠/直肠切除术、冠状动脉旁路移植、胰十二指肠切除、肺切除或食管切除的患者,评估RAI-rev、RAI-A、癌症校正RAI-rev及5变量改良衰弱指数对30天并发症与死亡的预测效能。结果显示仅RAI-rev对总队列及结肠/直肠切除和冠状动脉旁路移植患者的死亡有中等预测能力,所有指数对并发症预测均不佳,癌症校正未提升准确性。

要点

  • RAI-rev对总队列死亡预测C-statistic为0.71,对结肠/直肠切除为0.73。
  • 所有衰弱指数对30天并发症的预测效能均差。
  • 癌症校正RAI-rev未改善对并发症和死亡的预测准确性。

核心结论

  • 目前研究的衰弱指数对高风险手术患者30天并发症和死亡均非有效预测工具。

研究设计与样本

  • 基于美国外科质量改进计划数据库的回顾性研究,纳入2006至2017年接受结肠/直肠切除、冠状动脉旁路移植、胰十二指肠切除、肺切除或食管切除的患者共283545例。

主要发现

  • 总队列中RAI-rev预测死亡的C-statistic为0.71(95%CI 0.70-0.71,P<0.001)。
  • 结肠/直肠切除患者中RAI-rev预测死亡的C-statistic为0.73(95%CI 0.72-0.74,P<0.001),冠状动脉旁路移植患者为0.70(95%CI 0.68-0.73,P<0.001)。
  • RAI-A对结肠/直肠切除患者死亡预测的C-statistic为0.74(95%CI 0.73-0.74,P<0.001)。
  • 所有指数对并发症的预测效能均差。
  • 癌症校正RAI-rev未提高对并发症和死亡的预测准确性。

临床怎么用

  • 现有衰弱指数不宜单独用于高风险手术患者的30天并发症和死亡风险预测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the effectiveness of the revised Risk Analysis Index (RAI-rev), administrative Risk Analysis Index (RAI-A), cancer-corrected Risk Analysis Index [RAI-rev (cancer-corrected)], and 5-variable modified Frailty Index for predicting 30-day morbidity and mortality in patients undergoing high-risk surgery. BACKGROUND: There are several frailty composite measures, but none have been evaluated for predicting morbidity and mortality in patients undergoing high-risk surgery. METHODS: Using the National Surgical Quality Improvement Program database, we performed a retrospective study of patients who underwentcolectomy/proctectomy, coronary artery bypass graft (CABG), pancreaticoduodenectomy, lung resection, or esophagectomy from 2006 to 2017. RAI-rev, RAI-A, RAI-rev (cancer corrected), and 5-variable modified Frailty Index scores were calculated. Pearson's chi-square tests and C-statistics were used to assess the predictive accuracy of each score's logistic regression model. RESULTS: In the cohort of 283,545 patients, there were 178,311 (63%) colectomy/proctectomy, 38,167 (14%) pancreaticoduodenectomy, 40,328 (14%) lung resection, 16,127 (6%) CABG, and 10,602 (3%) esophagectomy cases. The RAI-rev was a fair predictor of mortality in the total cohort (C-statistic, 0.71, 95% CI 0.70-0.71, P < 0.001) and for patients who underwent colectomy/proctectomy (C-statistic 0.73, 95% CI 0.72-0.74, P < 0.001) and CABG (C-statistic 0.70, 95% CI 0.68-0.73, P < 0.001), but a poor predictor of mortality in all other operation cohorts. The RAI-A was a fair predictor of mortality for colectomy/proctectomy patients (C-statistic 0.74, 95% CI 0.73- 0.74, P < 0.001). All indices were poor predictors of morbidity. The RAI-rev (cancer corrected) did not improve the accuracy of morbidity and mortality prediction. CONCLUSION: The presently studied frailty indices are ineffective predictors of 30-day morbidity and mortality for patients undergoing high-risk operations.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Wan MA, Clark JM, Nuño M, et al. Can the Risk Analysis Index for Frailty Predict Morbidity and Mortality in Patients Undergoing High-risk Surgery? Ann Surg. 2020. PMID: 33214473. doi:10.1097/SLA.0000000000004626

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。